Sergio Todde

Institute of Molecular Bioimaging and Physiology — Italy

Medicine · Health Sciences

23h-index1.7kcitations80works7.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(28), Medical Imaging Techniques and Applications(22), Cancer, Hypoxia, and Metabolism(16), Receptor Mechanisms and Signaling(9), Radioactive Decay and Measurement Techniques(9)

Publications80 total

Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player
International Journal of Biological Sciences·2025· 1 citedOpen Access
Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging
Frontiers in Pharmacology·2025· 1 citedOpen Access
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method
EJNMMI Radiopharmacy and Chemistry·2024· 3 citedOpen Access
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry·2024· 2 citedOpen Access
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework
EJNMMI Radiopharmacy and Chemistry·2024· 29 citedOpen Access
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models
International Journal of Molecular Sciences·2023· 2 citedOpen Access
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'
European Journal of Nuclear Medicine and Molecular Imaging·2023· 2 citedOpen Access
Data from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Supplementary Table S1 from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Supplementary Figures S1-S9 from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Supplementary Materials and Methods from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Supplementary Figure Legends from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Supplementary Materials and Methods from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Supplementary Figures S1-S9 from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Supplementary Figure Legends from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Supplementary Table S1 from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Data from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2023Open Access
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry·2022· 4 citedOpen Access
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
EJNMMI Radiopharmacy and Chemistry·2022· 41 citedOpen Access
EANM guideline on quality risk management for radiopharmaceuticals
European Journal of Nuclear Medicine and Molecular Imaging·2022· 29 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Ferruccio Fazio(23), Mario Matarrese(19), Rosa Maria Moresco(18), M. Galli Kienle(16), Ângelo Rafael Carpinelli(13), Fulvio Magni(13), Clemens Decristoforo(11), Pasquale Simonelli(11), Dmitry Soloviev(9), E Turolla(9), Sara Belloli(8), Philip H. Elsinga(7), Martin Béhé(7), Jacek Koziorowski(7), Thomas L. Mindt(7), Petra Kolenc Peitl(7), Marianne Patt(6), Francesco Sudati(5), Nic Gillings(4), Olaug Hjelstuen(4)